Clinic
CCM Health
CCM Health was paid $4.29M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoCCM HEALTH
MONTEVIDEO, MN 56265
MONTEVIDEO, MN 56265
33aNPI1720086028assigned 07/11/2005
33bProvider typeClinic/Center
28Total paid$4.29M
24GClaims96,846
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Minnesota
Rank by total paid#16 of 250
Median peer was paid$274K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,514 | $185K | |
| 2019 | 13,551 | $539K | |
| 2020 | 9,880 | $491K | |
| 2021 | 14,911 | $829K | |
| 2022 | 18,882 | $947K | |
| 2023 | 22,585 | $1.04M | |
| 2024incomplete | 4,523 | $263K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 34,214 | 24,970 | $1.17M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 12,130 | 8,128 | $623K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.7% | 3,356 | 2,832 | $418K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.6% | 3,035 | 2,617 | $369K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.7% | 2,122 | 2,064 | $243K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 5.7% | 3,316 | 1,525 | $243K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.6% | 1,450 | 1,296 | $154K |
| 36415 | Collection of venous blood by venipuncture | 3.5% | 11,324 | 9,742 | $151K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 2,686 | 2,396 | $118K |
| 80053 | Comprehensive metabolic panel | 2.4% | 1,609 | 1,458 | $103K |
| X5622 | 1.7% | 1,248 | 1,197 | $74K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.6% | 1,505 | 1,328 | $68K |
75 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.2% | 477 | $50K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 325 | $49K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.1% | 2,720 | $45K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 1,160 | $44K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,066 | $31K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 828 | $28K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,041 | $27K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 495 | $24K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 415 | $22K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 224 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 457 | $17K |
| 87430 | <1% | 271 | $15K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 234 | $15K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 255 | $12K |
| 86140 | <1% | 407 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 119 | $11K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 188 | $11K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 579 | $8K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 87 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 131 | $8K |
| 81001 | <1% | 467 | $8K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 32 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 149 | $5K |
| J3490 | Unclassified drugs | <1% | 335 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 31 | $5K |
| 84484 | <1% | 62 | $5K | |
| 92551 | <1% | 830 | $5K | |
| 99188 | <1% | 541 | $4K | |
| A0425 | Ground mileage, per statute mile | <1% | 15 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 49 | $3K |
| 93793 | <1% | 359 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 861 | $3K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 29 | $3K |
| 0002A | <1% | 125 | $3K | |
| 83605 | <1% | 40 | $3K | |
| 0001A | <1% | 105 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 54 | $2K |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 127 | $2K |
| 80061 | Lipid panel | <1% | 49 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 38 | $2K |
| 90686 | <1% | 490 | $2K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 26 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 49 | $2K |
| 99417 | Prolong home eval add 15m | <1% | 26 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 34 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 38 | $1K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 19 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 63 | $900.77 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $876.84 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $851.81 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $830.40 |
| 85610 | <1% | 44 | $742.23 | |
| 99173 | <1% | 632 | $732.47 | |
| 87081 | <1% | 42 | $719.99 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $702.19 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 66 | $612.00 |
| 0011A | <1% | 22 | $600.29 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $471.46 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 86 | $458.77 |
| 0012A | <1% | 13 | $311.33 | |
| 83690 | <1% | 13 | $282.07 | |
| 85018 | <1% | 12 | $265.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 36 | $233.70 |
| 0124A | <1% | 13 | $133.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 13 | $132.90 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 31 | $127.63 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $116.41 |
| 96127 | <1% | 15 | $92.17 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 21 | $38.30 |
| 90723 | 0% | 17 | $0.00 | |
| 90648 | 0% | 88 | $0.00 | |
| 90685 | 0% | 14 | $0.00 | |
| 90670 | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANSPACH, DESERAE (CFO)